首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

市場調查報告書

商品編碼

1392012

診斷放射性同位素市場：依放射性同位素、應用、影像方式、疾病指示、最終使用者、地區

Diagnostic Radioisotopes Market, By Radioisotope, By Application, By Imaging Modality, By Disease Indication, By End User, By Geography

出版日期: 2023年11月09日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球診斷放射性同位素市場規模預計將從 2023 年的 56.7 億美元增至 2030 年的 103.6 億美元，預測期內複合年成長率為 9%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	56.7億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	9.00%	2030年市場規模預測	103.6億美元

圖 1. 2023 年診斷放射性同位素的全球市場佔有率（依地區分類）

由於慢性病的增加、醫學影像技術的進步以及對準確診斷程序的需求不斷成長，全球診斷放射性同位素市場正在經歷顯著成長。診斷放射性同位素是用於醫學影像診斷各種疾病和病症的放射性物質。這些放射性同位素發出輻射，可以透過診斷影像設備檢測到，使醫療保健專業人員能夠可視化和分析身體的內部結構。

市場動態：

全球診斷放射性同位素市場受到多種因素的影響。癌症、心血管疾病和神經系統疾病等慢性疾病的增加增加了對診斷放射性同位素的需求。這些放射性同位素用於各種成像技術，例如正子斷層掃描 (PET)、單光子發射電腦斷層掃描 (SPECT) 和伽馬攝影機，以檢測和診斷這些疾病。

然而，也存在阻礙市場成長的因素。診斷放射性同位素的高成本及其生產和使用的嚴格監管要求對市場成長構成了挑戰。放射性同位素的可得性有限以及某些同位素的半衰期短可能限制其在某些診斷程序中的使用。

儘管存在這些挑戰，市場上仍存在一些成長機會。 PET/CT 和 SPECT/CT 等混合成像技術的日益普及預計將推動對診斷放射性同位素的需求。此外，新型放射性同位素和放射性藥物的開拓以及成像技術的進步預計將出現新的市場機會。

例如，2023年3月16日，製藥公司Telix Pharmaceuticals Limited.向美國食品藥物管理局（FDA）提交了Illuccix（套件）的補充新藥認證（sNDA）。177 PSMA定向治療現在可用於選擇符合 PSMA 定向治療資格的轉移性前列腺癌患者。

本研究的主要特點

該報告對全球診斷放射性同位素市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率（CAGR%）。
本報告還揭示各個區隔市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
本報告還提供有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
本報告根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球診斷放射性同位素市場的主要企業。
該報告的見解將使行銷人員和經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略負責人資訊的決策。
全球診斷放射性同位素市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球診斷放射性同位素市場的各種策略矩陣來促進他們的決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
北非
中部非洲

第11章競爭形勢

GE Healthcare
Siemens Healthineers
Koninklijke Philips NV
Cardinal Health
Lantheus Holdings, Inc.
Bayer AG
Bracco
Eckert & Ziegler
Nordion（Canada）Inc.
NTP Radioisotopes
Curium
Jubilant Life Sciences Ltd
IRE
Isotopia Molecular Imaging Ltd.
Mallinckrodt Nuclear Medicine LLC
Jubilant DraxImage Inc.
Sumitomo Heavy Industries, Ltd.
Telix Pharmaceuticals Limited

第12章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI6190

Global diagnostic radioisotopes market size is expected to reach US$ 10.36 Bn by 2030, from US$ 5.67 Bn in 2023, at a CAGR of 9% during the forecast period

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 5.67 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	9.00%	2030 Value Projection:	US$ 10.36 Bn

Figure 1. Global Diagnostic Radioisotopes Market Share (%), By Region, 2023

Global diagnostic radioisotopes market is witnessing significant growth due to increasing prevalence of chronic diseases, advancements in medical imaging technology, and rising demand for accurate diagnostic procedures. Diagnostic radioisotopes are radioactive substances that are used in medical imaging to diagnose various diseases and conditions. These isotopes emit radiation that can be detected by imaging devices, allowing healthcare professionals to visualize and analyze the internal structures of the body.

Market Dynamics:

Global diagnostic radioisotopes market are influenced by several factors. Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders boosts demand for diagnostic radioisotopes. These isotopes are used in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma cameras to detect and diagnose these diseases.

However, there are certain restraints that may hinder the growth of the market. The high cost of diagnostic radioisotopes and the stringent regulatory requirements for their production and use pose challenges for market growth. The limited availability of radioisotopes and the short half-life of some isotopes may limit their use in certain diagnostic procedures.

Despite these challenges, the market presents several opportunities for growth. Increasing adoption of hybrid imaging techniques, such as PET/CT and SPECT/CT, is expected to boost demand for diagnostic radioisotopes. Moreover, the development of novel radioisotopes and radiopharmaceuticals, as well as advancements in imaging technology, are expected to create new opportunities in the market.

For instance, on March 16, 2023, Telix Pharmaceuticals Limited., a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved a supplementary New Drug Application (sNDA) for Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection) to enable its use for the selection of patients with metastatic prostate cancer, for whom 177Lu 177 PSMA-directed therapy is indicated.

Key features of the study:

This report provides in-depth analysis of the global diagnostic radioisotopes market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diagnostic radioisotopes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Cardinal Health, Lantheus Holdings, Inc., Bayer AG, Bracco, Eckert & Ziegler, Nordion (Canada) Inc., NTP Radioisotopes, Curium, Jubilant Life Sciences Ltd, IRE, Isotopia Molecular Imaging Ltd., Mallinckrodt Nuclear Medicine LLC, Jubilant DraxImage Inc., Sumitomo Heavy Industries, Ltd., and Telix Pharmaceuticals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global diagnostic radioisotopes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic radioisotopes market

Detailed Segmentation:

By Radioisotope
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- FDG
- Rubidium-82
- Others
By Application
- Diagnostic Application
- Therapeutic Application
By Imaging Modality
- SPECT
- PET
- Beta Emitters
By End User
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Academic & Research Institutes
- Others
By Indication
- Oncology
- Cardiology
- Neurology
- Thyroid
- Orthopedic
- Endocrinology
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top companies in Global Diagnostic Radioisotopes Market
- GE Healthcare
- Siemens Healthineers
- Koninklijke Philips N.V.
- Cardinal Health
- Lantheus Holdings, Inc.
- Bayer AG
- Bracco
- Eckert & Ziegler
- Nordion (Canada) Inc.
- NTP Radioisotopes
- Curium
- Jubilant Life Sciences Ltd
- IRE
- Isotopia Molecular Imaging Ltd.
- Mallinckrodt Nuclear Medicine LLC
- Jubilant DraxImage Inc.
- Sumitomo Heavy Industries, Ltd.
- Telix Pharmaceuticals Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Diagnostic Radioisotopes, By Radioisotope
- Market Diagnostic Radioisotopes, By Application
- Market Diagnostic Radioisotopes, By Imaging Modality
- Market Diagnostic Radioisotopes, By Indication
- Market Diagnostic Radioisotopes, By End User
- Market Diagnostic Radioisotopes, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders
- Restraints
High cost of diagnostic radioisotopes
- Opportunities
Increasing adoption of hybrid imaging techniques
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Diagnostic Radioisotopes Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Diagnostic Radioisotopes Market, By Radioisotope, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Technetium-99m
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Thallium-201
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Gallium-67
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Iodine-123
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
FDG
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Rubidium-82
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Diagnostic Radioisotopes Market, By Application, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Diagnostic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Therapeutic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Diagnostic Radioisotopes Market, By Imaging Modality, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
SPECT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
PET
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Beta Emitters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Diagnostic Radioisotopes Market, By Indication, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Thyroid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Diagnostic Radioisotopes Market, By End User, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

10. Global Diagnostic Radioisotopes Market, By Region, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,( US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
South Africa
North Africa
Central Africa

11. Competitive Landscape

GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers
Koninklijke Philips N.V.
Cardinal Health
Lantheus Holdings, Inc.
Bayer AG
Bracco
Eckert & Ziegler
Nordion (Canada) Inc.
NTP Radioisotopes
Curium
Jubilant Life Sciences Ltd
IRE
Isotopia Molecular Imaging Ltd.
Mallinckrodt Nuclear Medicine LLC
Jubilant DraxImage Inc.
Sumitomo Heavy Industries, Ltd.
Telix Pharmaceuticals Limited
Analyst Views